Randomized Phase II Study of Bevacizumab with Weekly Anetumab Ravtansine or Weekly Paclitaxel in Platinum-Resistant/refractory High Grade Ovarian Cancer (NCI Trial).

Husam A Alqaisi,David E Cohn, Jing-Yi Chern, Linda R Duska,Andrea Jewell, Bradley R Corr, Ira Seth Winer,Eugenia Girda, Marta A Crispens, Neesha C Dhani,Ainhoa Madariaga, Robert C Grant, Matthew Malaguti, Crystal Lee,Valerie Bowering, Horace Wong, Andrew Poothullil,Vanessa Speers,Lisa Wang, Philippe L Bedard,John C Brady, Andrew B Nixon, Li Chen, Claire O'Connor,William Zamboni, Tawyna McKee, Jeffrey A Moscow, Amit M Oza,Stephanie Lheureux

Clinical cancer research an official journal of the American Association for Cancer Research（2025）

Cited 0|Views0

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined